Clinical Trials Directory

Trials / Completed

CompletedNCT05753098

Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility

Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy on Improvement of Endometrial Thickness and Treatment of Unexplained Infertility

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
148 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

. This study aimed to determine and compare the effect of vaginal sildenafil citrate and estradiol valerate on endometrial thickness, blood flow and pregnancy rates in infertile women.

Detailed description

The study is a randomized controlled trial that was carried on 148 infertile women with unexplained infertility. Patients were divided into 3 groups. Group 1 included 48 patients who received oral estradiol valerate (Cyclo-Progynova 2mg, from day 8th till triggering of ovulation), another 50 patients in group 2 received oral Sildenafil (Respatio 20mg/12hr film coated tablets for 5 days starting from last day of menstruation till ovulation), while group 3 was the control one who included 50 patients were given ovulation induction with CC 50mg/12hr from 2nd to 7th day of cycle. Every patient underwent a transvaginal ultrasound to determine ovulation, number of follicles, and pregnancy rates. Miscarriage, ectopic pregnancy, and multiple pregnancies were tracked for 3 months, as were any adverse consequences.

Conditions

Interventions

TypeNameDescription
DRUGestrogen therapyoral estradiol valerate
DRUGSildenafilPDE5 inhibitor
DRUGClomiphene Citrate 50mgused for ovulation induction

Timeline

Start date
2021-01-15
Primary completion
2023-01-31
Completion
2023-01-31
First posted
2023-03-03
Last updated
2023-04-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05753098. Inclusion in this directory is not an endorsement.